 |
|
Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?
Manolis Nikolopoulos, Michelle A.L. Godfrey, Fareeda Sohrabi, Min Wong, Deepali Bhatte, Rekha Wuntakal
Obstet Gynecol Sci. 2021;64(6):506-516. Published online 2021 Sep 14 DOI: https://doi.org/10.5468/ogs.21137
|
|
Citations to this article as recorded by
 Risk Stratified Follow-Up for Endometrial Cancer: The Clinicians’ Perspective
Anumithra Amirthanayagam, Louise Boulter, Nessa Millet, Hilary J. McDermott, Jo Morrison, Alexandra Taylor, Tracie Miles, Lorna Coton, Esther L. Moss
Current Oncology.2023; 30(2): 2237. CrossRef Patient‐initiated follow‐up in women with early‐stage endometrial cancer: A long‐term follow‐up of the OPAL trial
Marina Chabert Rulanda, Ole Mogensen, Pernille Tine Jensen, Dorte Gilså Hansen, Chunsen Wu, Mette Moustgaard Jeppesen
BJOG: An International Journal of Obstetrics & Gynaecology.2023; 130(13): 1593. CrossRef Splenic sarcoid reaction mimicking metastases in patients after uterine cancer surgery: a report of two cases
Kei Kitamura, Toshiro Ogura, Ryoichi Miyamoto, Hiroyuki Ishida, Shinichi Matsudaira, Amane Takahashi, Hiroaki Kanda, Takashi Fukuda
Surgical Case Reports.2023;[Epub] CrossRef
|